We broke ground on a second cGMP facility for our #GeneTherapy treatments for skin conditions. The Astra facility is intended to support potential commercial production of B-VEC, formerly KB103, as well as ongoing R&D efforts. Full details here: http://bit.ly/2GuRPHQ pic.twitter.com/Xk6pVCTYZX
13:00 - 27. sij 2020.
0 replies
2 proslijeđena tweeta
4 korisnika označavaju da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.